R&B Strategies
Bringing people and technology together to venture into uncharted fields
R&B at Kaneka, the Dreamology Company

Biomanufacturing

Accelerated technological advances in recent years have greatly expanded the potential of biomanufacturing. This has made it possible to harness the power of living organisms to produce complex substances that cannot be produced by chemical processes. It has also enabled eco-friendly production technologies that use fermentation and culture processes without the need for high temperatures and pressures.
Kaneka is an advanced biomanufacturing company that started out with technologies for yeast and other fermentation. We have accumulated technologies in various fields such as pharmaceuticals, agriculture, and environmental fields.

Biomanufacturing

Kaneka’s Biomanufacturing Contributes to Three Strategic Areas

Kaneka’s Biomanufacturing Contributes to Three Strategic Areas

The Miraculous Polymer Green Planet™: A Creative Fusion of People and Technology

Green Planet™ is derived from 100% biomass and is highly biodegradable even in the ocean. We are implementing this miraculous polymer in response to the growing needs of society. It is the outcome of a creative fusion of various people and technologies at Kaneka and of many years of accumulated breeding and culture technology and process development technology in the field of polymer materials.

Progress in Social Implementation

In 2022, with new national laws and regulations being enforced, the public awareness of the issue of plastics further grew. Inquiries have surged from brand holders needing to reduce their use of disposable plastics. We are advancing our development of processing technology to meet this need and expanding applications.

(First use at a hotel chain) hotel amenity
                  (Tokyu Hotels Co., Ltd.)
(First use at a hotel chain) hotel amenity
(Tokyu Hotels Co., Ltd.)
Heat seal paper for confectionery (Bourbon Corporation)
Heat seal paper for confectionery (Bourbon Corporation)

Further Evolution of Green Planet™ Toward a Decarbonized Society

To help tackle the growing social issue of reducing GHG emissions, we are working to develop technologies that use carbon dioxide as a direct resource.
Research into producing Green Planet™ from carbon dioxide and hydrogen has already been successful at the laboratory level. Going forward, we will continue to develop technologies for breeding high-productivity microorganisms and for building the world’s first gas culture demonstration plant for practical use. We will also continue researching applications for producing a wide variety of polymers.

Further Evolution of Green PlanetTM Toward a Decarbonized Society

Kaneka Is a Leader in Biomanufacturing

Kaneka Is a Leader in Biomanufacturing
Product lines (partially) based on biomanufacturing in key strategic areas
(environment, medical & pharmaceutical, food & agriculture)

Biomanufacturing to Break Through the Food Crisis

Advances are being made in genome-editing technology for improving crops. We are moving ahead with deploying technology that will lead to the creation of new business models, focusing on combining two unique breeding technologies, the iPB method and the JT method.
In addition, we will combine our proprietary food production support technologies, such as anti-stress fertilizers and bio-pesticides, to expand into large-scale seed-related businesses.

Biomanufacturing to Break Through the Food Crisis

Biomanufacturing to Diversify Pharmaceutical Modalities

At Kaneka Eurogentec S.A., we have decided to increase our GMP* manufacturing capacity for mRNA. Production capacity will be about five times the current level. Kaneka Eurogentec provides drug discovery compa­nies with plasmid DNA, proteins, and oligonucleic acids as active pharmaceutical ingredients for biophar­maceuticals.
We have also started manufacturing services for mRNA since 2020, and we will continue to expand our business by enhancing our capabilities.

* GMP (Good Manufacturing Practice): A system for ensuring that products are consistently produced and controlled according to quality standards.

The Challenge of Bringing Regenerative Medicine and Cell Therapy to Society

Cellport Clinic YOKOHAMA, which is operated by Group company Biomaster, Inc., has established autol­ogous cell therapy technology and accumulated a world-leading clinical record of more than 1,300 cases.
In addition to the field of plastic surgery focusing on breast reconstruction, we will expand into the field of orthopedic surgery for conditions such as knee osteoarthritis.

PAGE TOP